Approach to acute or subacute myelopathy

William F. Schmalstieg, Brian G. Weinshenker

Research output: Contribution to journalArticlepeer-review

37 Scopus citations
Original languageEnglish (US)
Pages (from-to)S2-S8
Issue number18 SUPPL.1
StatePublished - Nov 2 2010
Externally publishedYes

Bibliographical note

Funding Information:
Dr. Schmalstieg reports no disclosures. Dr. Weinshenker has served on data safety monitoring boards for Novartis and Biogen Idec; serves on the editorial boards of Multiple Sclerosis , the Canadian Journal of Neurological Sciences , and the Turkish Journal of Neurology ; receives research support from the Guthy-Jackson Charitable Foundation; and receives license royalties from RSR Ltd. and may receive royalties from Mayo Medical Ventures for a patent/intellectual property re: Aquaporin-4 associated antibodies for diagnosis of neuromyelitis optica.

Cite this